Monte Rosa Therapeutics, Inc.
GLUE
$3.70
-$0.34-8.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 326.07M | 372.15M | 242.19M | 262.21M | 192.89M |
| Total Receivables | 1.41M | 173.00K | 595.00K | 9.84M | 601.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.80M | 5.12M | 8.43M | 5.85M | 5.54M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 332.28M | 377.44M | 251.21M | 277.90M | 199.04M |
|
|
|||||
| Total Current Assets | 332.28M | 377.44M | 251.21M | 277.90M | 199.04M |
| Net Property, Plant & Equipment | 55.60M | 56.31M | 58.81M | 61.14M | 62.46M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.32M | 4.98M | 5.07M | 5.08M | 5.25M |
| Total Assets | 393.20M | 438.73M | 315.08M | 344.11M | 266.75M |
|
|
|||||
| Total Accounts Payable | 6.49M | 17.22M | 3.98M | 6.47M | 6.83M |
| Total Accrued Expenses | 11.87M | 15.43M | 13.80M | 10.81M | 8.55M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.87M | 3.71M | 3.65M | 3.47M | 3.35M |
| Total Finance Division Other Current Liabilities | 37.00M | 120.59M | 20.22M | 21.60M | 22.57M |
| Total Other Current Liabilities | 37.00M | 120.59M | 20.22M | 21.60M | 22.57M |
| Total Current Liabilities | 59.22M | 156.95M | 41.64M | 42.35M | 41.29M |
|
|
|||||
| Total Current Liabilities | 59.22M | 156.95M | 41.64M | 42.35M | 41.29M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 38.00M | 39.00M | 40.05M | 40.89M | 41.84M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 20.82M | 19.85M | 27.93M | 36.21M | 31.10M |
| Total Liabilities | 118.04M | 215.80M | 109.62M | 119.44M | 114.23M |
|
|
|||||
| Common Stock & APIC | 670.19M | 664.88M | 659.80M | 655.51M | 553.07M |
| Retained Earnings | -391.70M | -438.59M | -452.03M | -428.17M | -397.86M |
| Treasury Stock & Other | -3.33M | -3.36M | -2.32M | -2.67M | -2.69M |
| Total Common Equity | 275.16M | 222.94M | 205.46M | 224.67M | 152.52M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 275.16M | 222.94M | 205.46M | 224.67M | 152.52M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 275.16M | 222.94M | 205.46M | 224.67M | 152.52M |
|
|
|||||